Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Fresenius Medical Care AG before investing.

In this article, we go over a few key elements for understanding Fresenius Medical Care AG’s stock price such as:

• Fresenius Medical Care AG’s current stock price and volume
• Why Fresenius Medical Care AG’s stock price changed recently
• Upgrades and downgrades for FMS from analysts
• FMS’s stock price momentum as measured by its relative strength

About Fresenius Medical Care AG (FMS)

Before we jump into Fresenius Medical Care AG’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Want to learn more about Fresenius Medical Care AG’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Fresenius Medical Care AG.

Fresenius Medical Care AG’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Fresenius Medical Care AG’s stock price was $25.660.

Fresenius Medical Care AG is down 0.16% from its previous closing price of $25.700.

During the last market session, Fresenius Medical Care AG’s stock traded between $25.330 and $25.710. Currently, there are approximately 317.36 million shares outstanding for Fresenius Medical Care AG.

Fresenius Medical Care AG’s price-earnings (P/E) ratio is currently at 6.8, which is low compared to the Health Care Providers & Services industry median of 26.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Fresenius Medical Care AG Stock Price History

Fresenius Medical Care AG’s (FMS) price is currently up 13.49% so far this month.

During the month of July, Fresenius Medical Care AG’s stock price has reached a high of $25.740 and a low of $22.670.

Over the last year, Fresenius Medical Care AG has hit prices as high as $27.640 and as low as $20.020. Year to date, Fresenius Medical Care AG’s stock is up 7.72%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Fresenius Medical Care AG Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Fresenius Medical Care AG’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Fresenius Medical Care AG’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Fresenius Medical Care AG’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Fresenius Medical Care AG’s current valuation based on AAII’s Value Grade is a A, which means it is considered to be Deep Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Fresenius Medical Care AG (FMS) by visiting AAII Stock Evaluator.

Relative Price Strength of Fresenius Medical Care AG

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Fresenius Medical Care AG has a weighted four-quarter relative price strength of -0.65%, which translates to a Momentum Score of 51 and is considered to be Average.

Want to learn more about how Fresenius Medical Care AG is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Fresenius Medical Care AG Stock Price: Bottom Line

As of July 31, 2026, Fresenius Medical Care AG’s stock price is $25.660, which is down 0.16% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Fresenius Medical Care AG stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.